Is your theranostics program ready for tomorrow? Siemens Healthineers eBlast

Theranostics for personalized cancer care

From targeted development to therapy solutions—precision oncology tools at every step of the theranostics care pathway

Comparison of 177Lu-PSMA-617 therapy cycle 1 and cycle 6 SPECT MIP images reveals decreased uptake, demonstrating the efficacy of this treatment.

Personalizing cancer care demands the right tools in order to get patients the right treatment at the right time.

Our comprehensive integrated value chain of precision oncology tools equips theranostics programs with state-of-the-art solutions at every step of the theranostics care pathway:
  • diagnosis and patient selection
  • personalized treatment
  • therapy response monitoring
  • follow-up and survivorship
Begin your program with our molecular imaging scanners with LSO crystals, True time of flight (TOF), and xSPECT Quant™ for SPECT/CT quantification to help you effectively and efficiently tailor cancer care for each patient.

Discover how we can help your theranostics program today.
Explore theranostics
Department of Molecular Imaging and Therapeutics, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York, USA
Twitter Icon   Facebook Icon   Instagram Icon   LinkedIn Icon   YouTube Icon
Contact Us | Privacy Policy
This email was sent by:
Siemens Healthcare GmbH | Henkestr. 127, 91052 Erlangen, Germany
Information for healthcare professionals. The Siemens Healthineers newsletter and websites, including but not limited to and its affiliated sites, provide an online resource for healthcare professionals
•  Do not reply to this email as it was sent from an unmonitored account.
•  Unsubscribe from the Molecular Imaging Insider.
•  Reset your password.
•  Contact support.
• Privacy Policy.
•  Email sent to: ., 671 N Glebe Road, Suite #1610, Arlington, VA 22203 USA
+1 520-298-1000